Low-density lipoprotein cholesterol response after statin initiation among persons living with human immunodeficiency virus-Reference-Cited by-同舟云学术

Low-density lipoprotein cholesterol response after statin initiation among persons living with human immunodeficiency virus

Published:2018-07 Issue:4 Volume:12 Page:988-998.e5
ISSN:1933-2874
Container-title:Journal of Clinical Lipidology
language:en
Short-container-title:Journal of Clinical Lipidology

Author:

Burkholder Greer A.,Muntner Paul,Zhao Hong,Mugavero Michael J.,Overton E. Turner,Kilgore Meredith,Drozd Daniel R.,Crane Heidi M.,Moore Richard D.,Mathews Wm. Christopher,Geng Elvin,Boswell Stephen,Floris-Moore Michelle,Rosenson Robert S.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference40 articles.

1. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Stone;Circulation,2014

2. National lipid association recommendations for patient-centered management of dyslipidemia: Part 2;Jacobson;J Clin Lipidol,2015

3. Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis;Islam;HIV Med,2012

4. Statin therapy and low-density lipoprotein cholesterol reduction in HIV-infected individuals after acute coronary syndrome: Results from the PACS-HIV lipids substudy;Boccara;Am Heart J,2017

5. A comparison of the effectiveness of lipid-lowering therapy between HIV- and non-HIV-infected subjects with hyperlipidaemia;Townsend;Int J STD AIDS,2007

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex differences in incident atherosclerotic cardiovascular disease events among women and men with HIV;AIDS;2023-05-03

2. Proprotein convertase subtilisin/kexin type 9 inhibitors: a turning point in HIV-associated dyslipidemia?;AIDS;2022-04-01

3. Long-term effects of evolocumab in participants with HIV and dyslipidemia: results from the open-label extension period;AIDS;2022-01-12

4. Cardiovascular risk assessment in people living with HIV compared to the general population;European Journal of Preventive Cardiology;2021-12-10

5. Mechanisms and primary prevention of atherosclerotic cardiovascular disease among people living with HIV;Current Opinion in HIV and AIDS;2021-05